Business, energy, technology, markets and global industry news from Business News Today

U.S. Patent and Trademark Office

PharmaDeviceNews U.S. Patent and Trademark Office
Representative image of pharmaceutical regulatory documents and medicine, illustrating Xeris Biopharma’s Keveyis patent allowance and its potential impact on rare disease treatment exclusivity.
Pharma & Biotech

Xeris wins key Keveyis patent allowance, but will it really slow generic pressure?

Find out how Xeris’ Keveyis patent allowance could reshape rare disease exclusivity, generic pressure and investor sentiment.

Read More